Akebia Therapeutics, Inc. - Filer Information

Symbol
AKBA on Nasdaq
Entity
Company
CIK
0001517022
EIN
208756903
Business address
245 First Street, 02142 Cambridge, MA
Phone
617-871-2098
State of incorporation
DE
Fiscal year end
December 31
Category
Accelerated filer
Smaller reporting company
All SEC filings
View on sec.gov
Get insider transactions for this issuer
Get financial reports for this company